BRIEF published on 07/21/2025 at 16:43, 4 months 14 days ago Half-Yearly Report S1 2025 of the ENCRES DUBUIT Liquidity Contract Liquidity Transactions Actions Gilbert Dupont DUBUIT Inks
BRIEF published on 02/28/2025 at 19:05, 9 months 4 days ago Dubuit Inks: Slight recovery despite a difficult context in 2024 Innovation Strategy Growth Economic Recovery Markets
BRIEF published on 10/31/2024 at 17:36, 1 year 1 month ago DUBUIT Inks 2024 Half-Yearly Review: Loss Reduction and New Projects Half-year Results Strategic Investments Loss Reduction DUBUIT Inks Growth Asia
BRIEF published on 10/31/2024 at 17:21, 1 year 1 month ago Dubuit Inks sells a building in Brazil as part of its restructuring Restructuring Global Competitiveness Key Markets Industrial Inks Sale Of Buildings
Published on 12/05/2025 at 02:35, 3 hours 37 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 12 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 7 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 12 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 42 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 21 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 47 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 57 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 2 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 12 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 27 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 28 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 11 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025